Novalis LifeSciences Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
39
- Portfolio
-
16
- Exits
-
13
Novalis LifeSciences General Information
Company Description
Founded in 2017, Novalis LifeSciences is a venture capital firm based in Portsmouth, New Hampshire. The firm invests in small to medium size life science companies operating in the biopharma therapeutics, diagnostics, and life science tools sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.novalislifesciences.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 170 Commerce Way
- Suite 200
- Portsmouth, NH 03801
- United States
Novalis LifeSciences Investments (39)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Telesis Bio | 06-Mar-2026 | PIPE | Discovery Tools (Healthcare) | Generating Revenue | ||
| Flywheel () | 09-Jan-2026 | Enterprise Systems (Healthcare) | Generating Revenue | |||
| Mercy BioAnalytics | 28-Aug-2025 | Decision/Risk Analysis | Generating Revenue | |||
| AIRNA | 31-Jul-2024 | Drug Discovery | Clinical Trials - General | |||
| Allurion Technologies | 01-Sep-2023 | Therapeutic Devices | Generating Revenue | |||
| BlueWhale Bio | 01-Aug-2023 | Drug Discovery | Clinical Trials - General | |||
| Orogen Therapeutics | 16-Jun-2023 | Drug Discovery | Clinical Trials - General | |||
| Telesis Bio | 05-Jun-2023 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Flywheel () | 03-Jun-2023 | Later Stage VC | Enterprise Systems (Healthcare) | Generating Revenue | ||
| Mercy BioAnalytics | 08-Mar-2023 | Later Stage VC | Decision/Risk Analysis | Generating Revenue |
Novalis LifeSciences Exits (13)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| etherna | 12-Oct-2026 | Merger/Acquisition | |
| BioQ Pharma | 01-May-2025 | ||
| Sherlock Biosciences | 19-Dec-2024 | ||
| Cerevel Therapeutics | 01-Aug-2024 | ||
| AgBiome | 11-Apr-2024 | ||
| Allurion Technologies | 01-Aug-2023 | ||
| Ginkgo Bioworks | 16-Sep-2021 | ||
| Biotalys | 02-Jul-2021 | ||
| Quantum-Si | 10-Jun-2021 | Reverse Merger | |
| Decipher Urologic Cancers | 12-Mar-2021 | Merger/Acquisition |
Novalis LifeSciences Investments by Industry, Year, and Region
Novalis LifeSciences Co-Investors (89)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Anterra Capital | 3 |
|
|
||
| ARCH Venture Partners |
|
|
|||
| Finistere Ventures |
|
|
|||
| Northpond Ventures |
|
|
|||
| iSelect Fund |
|
|
Novalis LifeSciences FAQs
-
What is Novalis LifeSciences?
Founded in 2017, Novalis LifeSciences is a venture capital firm based in Portsmouth, New Hampshire.
-
When was Novalis LifeSciences founded?
Novalis LifeSciences was founded in 2017.
-
Where is Novalis LifeSciences headquartered?
Novalis LifeSciences is headquartered in Portsmouth, NH.
-
What is Novalis LifeSciences's total asset value?
Novalis LifeSciences has around in total assets under management.
-
How many investments has Novalis LifeSciences made?
Novalis LifeSciences has made 39 investments.
-
What has Novalis LifeSciences invested in?
Novalis LifeSciences has made numerous investments in companies like Telesis Bio, Flywheel (), and Mercy BioAnalytics within the Discovery Tools (Healthcare), Enterprise Systems (Healthcare), and Decision/Risk Analysis industries.
-
What has Novalis LifeSciences invested in recently?
Novalis LifeSciences's latest investment was on 06-Mar-2026 in Telesis Bio, a company within the Discovery Tools (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process